<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>University of Kashan</PublisherName>
				<JournalTitle>Journal of Nanostructures</JournalTitle>
				<Issn>2251-7871</Issn>
				<Volume>15</Volume>
				<Issue>4</Issue>
				<PubDate PubStatus="epublish">
					<Year>2025</Year>
					<Month>10</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Al2O3-MgO Hybrid Nanoparticles as an Effective Nanocarrier for Lenalidomide as Anti-Cancer Drug for Treatment of Multiple Myeloma, Smoldering Myeloma, and Myelodysplastic Syndromes</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>2237</FirstPage>
			<LastPage>2250</LastPage>
			<ELocationID EIdType="pii">115164</ELocationID>
			
<ELocationID EIdType="doi">10.22052/JNS.2025.04.063</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Dilnora</FirstName>
					<LastName>Raxmatova</LastName>
<Affiliation>Bukhara State Medical Institute named after Abu Ali ibn Sino, Bukhara, Uzbekistan</Affiliation>

</Author>
<Author>
					<FirstName>Khabibjon</FirstName>
					<LastName>Mirzamurodov</LastName>
<Affiliation>Bukhara State Medical Institute named after Abu Ali ibn Sino, Bukhara, Uzbekistan</Affiliation>

</Author>
<Author>
					<FirstName>Nasiba</FirstName>
					<LastName>Kudratova</LastName>
<Affiliation>Tashkent State Medical University, Tashkent, Uzbekistan</Affiliation>

</Author>
<Author>
					<FirstName>Shodiyor</FirstName>
					<LastName>Boboyev</LastName>
<Affiliation>Samarkand State University named after Sharof Rashidov, Uzbekistan</Affiliation>

</Author>
<Author>
					<FirstName>Xamidullo</FirstName>
					<LastName>Fozilov</LastName>
<Affiliation>Samarkand State University named after Sharof Rashidov, Uzbekistan</Affiliation>

</Author>
<Author>
					<FirstName>Safiya</FirstName>
					<LastName>Fayziyeva</LastName>
<Affiliation>Bukhara State Pedagogical Institute, Bukhara, Uzbekistan</Affiliation>

</Author>
<Author>
					<FirstName>Olim</FirstName>
					<LastName>Turakulov</LastName>
<Affiliation>Jizzakh branch of the National University of Uzbekistan, Jizzakh, Uzbekistan</Affiliation>

</Author>
<Author>
					<FirstName>Makhfuza</FirstName>
					<LastName>Ruzmetova</LastName>
<Affiliation>Mamun University, Khorezm, Uzbekistan</Affiliation>

</Author>
<Author>
					<FirstName>Najmiddin</FirstName>
					<LastName>Bakaev</LastName>
<Affiliation>Asia International University, Bukhara, Uzbekistan</Affiliation>

</Author>
<Author>
					<FirstName>Adolat</FirstName>
					<LastName>Jumaboyeva</LastName>
<Affiliation>Urgench State Pedagogical Institute, Urgench, Uzbekistan</Affiliation>

</Author>
<Author>
					<FirstName>Muxtor</FirstName>
					<LastName>Turaev</LastName>
<Affiliation>Bukhara State University, Bukhara , Uzbekistan</Affiliation>

</Author>
<Author>
					<FirstName>Abdukhakim</FirstName>
					<LastName>Abdullaev</LastName>
<Affiliation>National Pedagogical University of Uzbekistan, Tashkent, Uzbekistan</Affiliation>

</Author>
<Author>
					<FirstName>Anvar</FirstName>
					<LastName>Ziyadullayevich Avlokulov</LastName>
<Affiliation>Tashkent State University of Economics, Tashkent, Uzbekistan</Affiliation>

</Author>
<Author>
					<FirstName>Otabek</FirstName>
					<LastName>Mirzayev</LastName>
<Affiliation>Urgench State University, Urgench, Uzbekistan</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2025</Year>
					<Month>05</Month>
					<Day>04</Day>
				</PubDate>
			</History>
		<Abstract>In this study, Al2O3–MgO hybrids were synthesized via aqueous, surfactant-free processing, yielding ≈84% isolated solid and a surface zeta potential of +32 ± 2 mV. LEN was loaded by a 24 h incubation (1:5 drug: carrier w/w) in pH 6.5 buffer, achieving loading capacity (LC) 12.4 ± 0.3% and encapsulation efficiency (EE) 93.1 ± 1.1%. Loading and purity were quantified by HPLC (302 nm; tR 6.8 min) with daily calibration (0.5–50 μg mL−1, R2 ≥ 0.9999). In vitro release used a dialysis-bag method under sink conditions at pH 7.4 and 5.0 (37 °C); cumulative release was UV-Vis monitored (302 nm) and corrected for dilution, revealing near-zero-order kinetics at pH 7.4 and accelerated release at pH 5.0. LEN-loaded Al2O3–MgO demonstrated a 4–6-fold potency advantage over free LEN across MM and MDS cell lines, with negligible toxicity from empty carriers. Confocal imaging showed lysosomal trafficking as the predominant uptake route, aligning with the observed pH-responsive release profile. The system maintains carrier integrity after release and demonstrates high drug-loading efficiency with sustained release, supporting improved therapeutic indices. </Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Nanoparticles</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Nanocarrier</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Lenalidomide</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Anti-cancer</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">treatment</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Multiple myeloma</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://jns.kashanu.ac.ir/article_115164_baeada39638b4a20837972f637d85988.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
